Boerhavia diffusa Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | B. repens Linn. B. procumbens Roxb. |
| Family | Nyctaginaceae. |
| Habitat | Throughout India as a weed. |
| English | Horse-purslane, Hogweed. |
| Ayurvedic | Rakta-punarnavaa, Punarnavaa, Katthilla, Shophaghni, Shothaghni. Varshaabhu (also equated with Trianthema portulacastrum Linn., which exhibits anti-inflammatory, antipyretic and analgesic activity). |
| Unani | Itsit, Bishkhaparaa. |
| Siddha / Tamil | Mookkirattai. |
| Folk | Gadaha-purnaa. |
| Action | Diuretic, anti-inflammatory, antiarthritic, spasmolytic, antibacterial (used for inflammatory renal diseases, nephrotic syndrome, in cases of ascites resulting from early cirrhosis of liver and chronic peritonitis, dropsy associated with chronic Bright’s diseases, for serum uric acid levels). Root—anticonvulsant, analgesic, expectorant, CNS depressant, laxative, diuretic, abortifacient. |
| Key Application | As diuretic, hepatoprotective. (Indian Herbal Pharmacopoeia.) |
| Dosage | Whole plant—20–30 g for decoction (API Vol. I); root—1–3 g powder; 10–20 ml fresh juice. (API Vol. III.) |
| Taxonomic Cohort | Genus Boerhavia (2 documented species); Family Nyctaginaceae (5 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Boerhavia diffusa (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Nyctaginaceae (primary family classification: Nyctaginaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. repens Linn. B. procumbens Roxb, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India as a weed.
Across classical and vernacular Indian systems of medicine, Boerhavia diffusa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Horse-purslane, Hogweed; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Rakta-punarnavaa, Punarnavaa, Katthilla, Shophaghni, Shothaghni. Varshaabhu (also equated with Trianthema portulacastrum Linn., which exhibits anti-inflammatory, antipyretic and analgesic activity); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Itsit, Bishkhaparaa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Mookkirattai; in regional Indian folk and vernacular ethnobotany as Gadaha-purnaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Boerhavia diffusa are: Diuretic, anti-inflammatory, antiarthritic, spasmolytic, antibacterial (used for inflammatory renal diseases, nephrotic syndrome, in cases of ascites resulting from early cirrhosis of liver and chronic peritonitis, dropsy associated with chronic Bright’s diseases, for serum uric acid levels). Root—anticonvulsant, analgesic, expectorant, CNS depressant, laxative, diuretic, abortifacient. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: As diuretic, hepatoprotective. (Indian Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Boerhavia diffusa establish the following evidence base: B. repanda, synonym B. chinensis Linn., roots exhibited antihepatotoxic activity against carbon tetrachloride galactosamine-and paracetamolinduced intoxication in rats. Powdered root gave encouraging results in spermatorrhoea and leucorrhoea. The chloroform and methanolic extracts of the roots and aerial parts of B. diffusa also exhibited antihepatotoxic activity against carbon tetrachlorideinduced intoxication in rats. Punarnavaa is official in IP as a diuretic. The diuretic action of the drug is attributed to the presence of xanthone, beta-ecdysone. Flavonoid, arbinofuranoside, present in the drug, was found to lower serum uric acid in experimental animals, as also in humans. Punarnavaa has been reported to increase serum protein level and reduce urinary protein extraction in clinical trials in patients suffering with nephrotic syndrome. The activity is attributed to the presence of rotenoids in various parts of the plant. An antifibrinolytic agent, punarnavoside, has been found to stop IUCD-induced bleeding in monkeys. The drug contains quinolizidine alkaloids.
In specialized pharmacognostic classifications, Boerhavia diffusa is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Boerhavia diffusa dried herb.

Botanical Reference 1: Boerhavia diffusa — Botanical specimen

Botanical Reference 2: Boerhavia diffusa — Botanical specimen

Botanical Reference 3: Boerhavia diffusa — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Boerhavia comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Boerhavia verticillata (Action: See B. diffusa). Comparing Boerhavia diffusa alongside its congeners in genus Boerhavia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Nyctaginaceae encompasses 5 documented medicinal species (0.28% of the 1,814-species flora). Other representative medicinal members of Nyctaginaceae include: Boerhavia verticillata (Shveta Punarnavaa), Mirabilis jalapa (Trisandhi), Pisonia aculeata (Baghachuur), Pisonia grandis (Lettuce tree). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 5 medicinal species of family Nyctaginaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Boerhavia diffusa are prescribed as follows: Whole plant—20–30 g for decoction (API Vol. I); root—1–3 g powder; 10–20 ml fresh juice. (API Vol. III.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Boerhavia diffusa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.